background logo image

Episode 175

New York Times: Can a Keto Diet Really Improve Mental Health?

Listen, Watch & Subscribe on:

Watch

New York Times: Can a Keto Diet Really Improve Mental Health?

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Key Highlights

  • The New York Times published a follow-up piece taking a deeper, more open look at whether ketogenic diets could help serious mental illnesses like schizophrenia, bipolar disorder, and depression, moving past its earlier cautious framing.
  • The article highlighted promising pilot studies from researchers at Stanford, the University of Edinburgh, and Ohio State University, noting that larger randomized controlled trials are now concluding or still underway.
  • Beyond the science, the piece featured personal stories from Maya Schumer and Lewis Anstee, individuals who say ketogenic and metabolic therapies helped them reclaim their lives after years of limited progress with standard treatment.
  • Ketogenic therapy is described as an adjunct to standard psychiatric care rather than a cure or replacement for medication, and any use of it should involve a knowledgeable clinician.
  • The episode frames this coverage as encouraging, since mainstream attention from outlets like the Times reflects a growing, evolving field offering real hope to people who haven’t found relief through medication alone.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

A New Hope for Depression: The Power of Ketogenic Therapy
Podcast

A New Hope for Depression: The Power of Ketogenic Therapy

New research highlighted by Metabolic Mind suggests that ketogenic therapy may be a promising adjunctive treatment for depression. In this episode, Dr. Bret Scher reviews a remote 14-week pilot study, the KIND Trial, and a larger meta-analysis showing that ketogenic diets may help reduce depression symptoms, anxiety, and anhedonia, while offering new hope for people who have not responded fully to standard treatments.

Read more

Metabolic Psychiatry: A New Lens on Mental Health
Stories

Metabolic Psychiatry: A New Lens on Mental Health

Across decades in clinical practice, I’ve noticed a glaring pattern: when people improve their metabolic health, their mental health often improves too. Their moods stabilize. Their anxiety eases….

Learn more

Ketogenic Therapy in Psychiatry: What the Experts Agree On
Podcast

Ketogenic Therapy in Psychiatry: What the Experts Agree On

A new Delphi consensus paper published in Frontiers in Nutrition provides clinicians with practical guidance on using ketogenic metabolic therapy for mental health. Developed by experts across psychiatry, nutrition, and research, the paper outlines candidate selection, safety protocols, and monitoring standards to help healthcare providers confidently integrate ketogenic therapy into clinical practice as interest and research in metabolic psychiatry continue to grow.

Learn more

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)
Podcast

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)

In part two of Metabolic Mind’s series on treatment resistant depression, Dr. Bret Scher and psychiatrist Dr. Georgia Ede review the leading next step treatment options beyond standard antidepressants. They discuss neurostimulation therapies like ECT, transcranial magnetic stimulation, and vagus nerve stimulation, along with rapid acting approaches such as ketamine, FDA approved esketamine (Spravato), and psilocybin. Learn how these treatments differ in effectiveness, session requirements, side effects, cost, and accessibility, and why response prediction remains difficult. The episode also previews part three, focused on lifestyle and metabolic interventions including diet, exercise, and other foundational strategies that may address root causes of depression.

Learn more

A New Hope for Depression: The Power of Ketogenic Therapy
Podcast

A New Hope for Depression: The Power of Ketogenic Therapy

New research highlighted by Metabolic Mind suggests that ketogenic therapy may be a promising adjunctive treatment for depression. In this episode, Dr. Bret Scher reviews a remote 14-week pilot study, the KIND Trial, and a larger meta-analysis showing that ketogenic diets may help reduce depression symptoms, anxiety, and anhedonia, while offering new hope for people who have not responded fully to standard treatments.

Read more

Metabolic Psychiatry: A New Lens on Mental Health
Stories

Metabolic Psychiatry: A New Lens on Mental Health

Across decades in clinical practice, I’ve noticed a glaring pattern: when people improve their metabolic health, their mental health often improves too. Their moods stabilize. Their anxiety eases….

Learn more

Ketogenic Therapy in Psychiatry: What the Experts Agree On
Podcast

Ketogenic Therapy in Psychiatry: What the Experts Agree On

A new Delphi consensus paper published in Frontiers in Nutrition provides clinicians with practical guidance on using ketogenic metabolic therapy for mental health. Developed by experts across psychiatry, nutrition, and research, the paper outlines candidate selection, safety protocols, and monitoring standards to help healthcare providers confidently integrate ketogenic therapy into clinical practice as interest and research in metabolic psychiatry continue to grow.

Learn more

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)
Podcast

The Truth About Treatment-Resistant Depression: Part Two (TMS and Psychedelics)

In part two of Metabolic Mind’s series on treatment resistant depression, Dr. Bret Scher and psychiatrist Dr. Georgia Ede review the leading next step treatment options beyond standard antidepressants. They discuss neurostimulation therapies like ECT, transcranial magnetic stimulation, and vagus nerve stimulation, along with rapid acting approaches such as ketamine, FDA approved esketamine (Spravato), and psilocybin. Learn how these treatments differ in effectiveness, session requirements, side effects, cost, and accessibility, and why response prediction remains difficult. The episode also previews part three, focused on lifestyle and metabolic interventions including diet, exercise, and other foundational strategies that may address root causes of depression.

Learn more